These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18463361)

  • 1. Reducing the economic burden of HPV-related diseases.
    Mayeaux EJ
    J Am Osteopath Assoc; 2008 Apr; 108(4 Suppl 2):S2-7. PubMed ID: 18463361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus, cervical cancer, and the vaccines.
    Tovar JM; Bazaldua OV; Vargas L; Reile E
    Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and natural history of genital human papillomavirus infection.
    Weaver BA
    J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S2-8. PubMed ID: 16729554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of mucosal human papillomavirus infection and associated diseases.
    Trottier H; Burchell AN
    Public Health Genomics; 2009; 12(5-6):291-307. PubMed ID: 19684442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus: the burden of infection.
    Wiley D; Masongsong E
    Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S3-14. PubMed ID: 16729902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for preventing HPV-related anogenital infection and neoplasia.
    Ferris DG
    J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S9-13. PubMed ID: 16729555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and natural history of HPV.
    Cox JT
    J Fam Pract; 2006 Nov; Suppl():3-9. PubMed ID: 17366752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genital human papillomavirus infection.
    Dunne EF; Markowitz LE
    Clin Infect Dis; 2006 Sep; 43(5):624-9. PubMed ID: 16886157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination as a prevention strategy for human papillomavirus-related diseases.
    Kahn JA
    J Adolesc Health; 2005 Dec; 37(6 Suppl):S10-6. PubMed ID: 16310136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of genital human papillomavirus infection.
    Trottier H; Franco EL
    Vaccine; 2006 Mar; 24 Suppl 1():S1-15. PubMed ID: 16406226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing human papillomavirus vaccine efficacy and safety.
    Hendrix SL
    J Am Osteopath Assoc; 2008 Apr; 108(4 Suppl 2):S8-S12. PubMed ID: 18463363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus associated with genital infection.
    Ljubojević S; Lipozencić J; Grgec DL; Prstacić R; Skerlev M; Mokos ZB
    Coll Antropol; 2008 Sep; 32(3):989-97. PubMed ID: 18982779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus and cervical cancer: burden of illness and basis for prevention.
    Trottier H; Franco EL
    Am J Manag Care; 2006 Dec; 12(17 Suppl):S462-72. PubMed ID: 17203990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STD-prevention counseling practices and human papillomavirus opinions among clinicians with adolescent patients--United States, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(41):1118-20. PubMed ID: 17060897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming barriers to adherence to HPV vaccination recommendations.
    Dempsey AF; Davis MM
    Am J Manag Care; 2006 Dec; 12(17 Suppl):S484-91. PubMed ID: 17203992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.